| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.19 | 0.3 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.3 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.055 | 0.3 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.032 | 0.3 |